Astrid M van Strien1, Carolina J P W Keijsers2, Hieronymus J Derijks3, Rob J van Marum4. 1. Department of Geriatric Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands a.v.strien@jbz.nl. 2. Department of Geriatric Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands. 3. Hospital Pharmacy ZANOB, 's-Hertogenbosch, the Netherlands. 4. Department of Geriatric Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands Department of General Practice and Elderly Care Medicine VU University Medical Center, Amsterdam, the Netherlands.
Abstract
INTRODUCTION: Many patients experience side effects during treatment with antipsychotics. This article reviews the clinical use and psychometric characteristics of rating scales used to assess side effects in patients treated with antipsychotics. METHODS: A systematic literature search was performed using the electronic databases PubMed and Embase, with predefined search terms. RESULTS: In total, 52 different scales were used in the 440 articles retrieved. For multiple side effects measured with one scale, the Udvalg for Kliniske Undersøgelser Side Effects Rating Scale for Clinicians was used the most, whereas the Liverpool University Neuroleptic Side Effect Rating Scale had the best psychometric characteristics (Cronbach's α 0.81 and test-retest reliability 0.89). The Simpson Angus Scale was used the most to rate extrapyramidal side effects, although the Maryland Psychiatric Research Center scale had the best characteristics (Cronbach's α 0.80, test-retest reliability 0.92 and inter-rater reliability 0.81-0.90). The Arizona Sexual Experience Scale was used the most to assess sexual dysfunction, but the Antipsychotics and Sexual Functioning Questionnaire and the Nagoya Sexual Functioning Questionnaire had the best characteristics. CONCLUSION: This review will help researchers and clinicians make a purpose-oriented choice of which scale to use. SYSTEMATIC REVIEW REGISTRATION NUMBER: CRD42014013010.
INTRODUCTION: Many patients experience side effects during treatment with antipsychotics. This article reviews the clinical use and psychometric characteristics of rating scales used to assess side effects in patients treated with antipsychotics. METHODS: A systematic literature search was performed using the electronic databases PubMed and Embase, with predefined search terms. RESULTS: In total, 52 different scales were used in the 440 articles retrieved. For multiple side effects measured with one scale, the Udvalg for Kliniske Undersøgelser Side Effects Rating Scale for Clinicians was used the most, whereas the Liverpool University Neuroleptic Side Effect Rating Scale had the best psychometric characteristics (Cronbach's α 0.81 and test-retest reliability 0.89). The Simpson Angus Scale was used the most to rate extrapyramidal side effects, although the Maryland Psychiatric Research Center scale had the best characteristics (Cronbach's α 0.80, test-retest reliability 0.92 and inter-rater reliability 0.81-0.90). The Arizona Sexual Experience Scale was used the most to assess sexual dysfunction, but the Antipsychotics and Sexual Functioning Questionnaire and the Nagoya Sexual Functioning Questionnaire had the best characteristics. CONCLUSION: This review will help researchers and clinicians make a purpose-oriented choice of which scale to use. SYSTEMATIC REVIEW REGISTRATION NUMBER: CRD42014013010.
Authors: C U Correll; Ofer Agid; Benedicto Crespo-Facorro; Andrea de Bartolomeis; Andrea Fagiolini; Niko Seppälä; Oliver D Howes Journal: CNS Drugs Date: 2022-06-27 Impact factor: 6.497
Authors: Michael J Crawford; Lavanya Thana; Rachel Evans; Alexandra Carne; Lesley O'Connell; Amy Claringbold; Arunan Saravanamuthu; Rebecca Case; Jasna Munjiza; Sandra Jayacodi; Joseph G Reilly; Elizabeth Hughes; Zoe Hoare; Barbara Barrett; Verity C Leeson; Carol Paton; Patrick Keown; Sofia Pappa; Charlotte Green; Thomas Re Barnes Journal: Health Technol Assess Date: 2020-09 Impact factor: 4.014
Authors: T Wykes; J Evans; C Paton; T R E Barnes; D Taylor; R Bentall; B Dalton; T Ruffell; D Rose; S Vitoratou Journal: Psychol Med Date: 2017-04-19 Impact factor: 7.723
Authors: Torleif Ruud; Karin Drivenes; Robert E Drake; Vegard Øksendal Haaland; Matthew Landers; Bjørn Stensrud; Kristin S Heiervang; Lars Tanum; Gary R Bond Journal: Adm Policy Ment Health Date: 2020-11
Authors: Renly Lim; Lisa Kalisch Ellett; Elizabeth E Roughead; Phaik Yeong Cheah; Nashwa Masnoon Journal: Int J Environ Res Public Health Date: 2021-11-12 Impact factor: 4.614
Authors: Robert C Wolf; Dusan Hirjak; Stefan Fritze; Fabio Sambataro; Katharina M Kubera; Geva A Brandt; Andreas Meyer-Lindenberg Journal: Eur Arch Psychiatry Clin Neurosci Date: 2021-11-27 Impact factor: 5.760